Veronique has a history in life sciences and health tech. She has leveraged this background for the last several years in venture capital, and supports start-ups through the early chapters of their success story.
Co-Founder and Managing Partner, Advent France Biotechnology
Matthieu brings 12 years of experience in venture capital and operations, having spent a decade in tech transfer as Managing Partner at Inserm Transfert Initiative. He handled investments in 14 seed-stage companies. He also served as VP Operations & Business Development at TherAchon and AAVlife, 2 French biotechnology start-ups, and as a board member of 7 others (Axilum Robotics, BioAxial, Aelis Farma, Enyo Pharma, Hemarina, Sensorion and Eyevensys). Matthieu founded Advent France Biotechnology with Alain Huriez in 2016.
Matthieu not only brings an experience of early stage investor managing financial and operational strategies, but also a strong network of researchers, entrepreneurs and technology transfer officers with whom he has forged significant partnerships.
Matthieu holds a Masters in Finance & Management and an MSc from ESIEE (Paris).
Jan Van den Bossche
Jan Van den Bossche holds a Master Degree in Applied Economic Sciences at the KULeuven. He worked for more than 12 years as a biotech analyst at Petercam. He was involved in numerous public and private transactions of Belgian and Dutch Biotech companies, such as ThromboGenics, Tigenix, UCB, AMT (Uniqure), IBA, MDxHealth . Before he joined Fund+, he was for more than 2 years part of the investor relations team at the Dutch life sciences and materials sciences company DSM (Geleen, NL). He serves on the board of Octimet, Aelin Therapeutics and Immunic Inc.
Managing Director and Head of Healthcare Investment, INKEF Capital
Roel Bulthuis is a Managing Director and head of the Healthcare investment team at INKEF Capital. Roel combines close to 20 years of experience across venture capital, pharma business development and M&A and healthcare investment banking. Prior to joining INKEF he served as SVP and Managing Director of M-Ventures which he created and developed into a leading CVC fund. Prior to that, he served in senior positions in global business development and M&A at Merck Serono and in the healthcare investment banking team at Fortis Bank. Roel is a Kauffman Fellow and passionate about continuously challenging the status quo. Roel holds a Msc. in Biopharmaceutical Sciences from Leiden University and an MBA in Finance from the Helsinki School of Economics.
Healthcare Investment Analyst, INKEF Capital
Rianne Ellenbroek is an analyst in the Healthcare investment team at INKEF Capital. She is involved in sourcing and evaluating investment opportunities, and supporting portfolio companies in the healthcare team. Rianne joins INKEF from the academic community where she was a medical biologist in regenerative medicine. She obtained her PhD at Leiden University while performing part of her activities at biotech company Galapagos. Winning a grant facilitated her to take a position as postdoctoral fellow at the Kovler Diabetes Center at the University of Chicago. Next to performing her research, she became a fellow at the university’s Tech Transfer Office which has sparked her interest in the early stages of life sciences ventures.
Senior Director of Global Markets and External Innovation, Johnson & Johnson Medical Devices
Sarah F. Fisher is a Senior Director, Global External Innovation, for Johnson & Johnson. She specializes in shaping the external environment and sourcing collaborative partners for global go-to-market strategy and execution of novel service and technology introductions.
Sarah has a combined 17 years of cross-functional innovation and new venture experience across Medtech, Healthtech, and Lifesciences new ventures in global markets. She was awarded the first-ever Corporate Entrepreneur accolade by Corporate Entrepreneurs, LLC. and is the head of the healthcare arm of the international venture club based in the EU.
She completed her Masters of Business Administration in Entrepreneurship at Babson College in Wellesley, MA and her post -graduate diploma in Global Business at the University of Oxford in Oxford, UK.
Principal, Philips Health Technology Ventures
Lara is Head of the European venture capital activities for Philips, includes running the Philips Health Technology Venture Fund focused on investments in early-stage digital health companies to drive strategic value-add relationships with Philips. Looking for driven entrepreneurs that are passionate and capable to address (part of) the quadruple aim in healthcare, improving outcomes and lowering costs while increasing patient and staff satisfaction. Passionate about technology, strategic investing and working together with great teams to scale their companies bringing strategic and industry expertise of Philips to the table.